Simon N.R. Harford - Jan 19, 2023 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
CFO and Treasurer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jan 19, 2023
Transactions value $
-$77,789
Form type
4
Date filed
1/20/2023, 03:05 PM
Previous filing
Oct 25, 2022
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$77.8K -1.78K -5.14% $43.80 32.8K Jan 19, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 13,497 shares of common stock and 19,294 restricted stock units. Includes 1,272 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on November 30, 2022.